Claret Capital Closes €575M Fund as Venture Debt Demand Surges in Europe

London-based venture debt manager Claret Capital Partners has closed its fourth flagship fund, Claret European Growth Capital Fund IV, at €575 million. The vehicle, which targets growth-stage technology and life sciences businesses across Europe, arrives at a critical juncture for the continent's startup ecosystem. As traditional equity rounds remain highly selective and heavily concentrated in artificial intelligence, venture debt is increasingly positioned as an essential alternative for mature, revenue-generating companies seeking to scale without heavy dilution.

The new fund will back European growth-stage companies with loans typically ranging from €5 million to €50 million. Claret's strategy focuses on businesses that have established product-market fit and predictable revenues but require capital to fund acquisitions, international expansion, or working capital. By offering debt rather than equity, the firm allows founders and existing venture backers to preserve ownership stakes while navigating a valuation environment that remains depressed compared to the 2021 peak.

The successful €575 million raise underscores a resilient appetite among limited partners for private credit and venture debt yield. In a high-interest-rate environment where exit activity via IPOs or acquisitions remains sluggish, venture debt funds offer limited partners more predictable, income-generating returns compared to long-duration equity funds. For Claret, this fourth vintage represents a scaling up of its capital base, reflecting how deeply integrated debt has become within the capital stack of European scaleups.

For European founders, Claret’s fresh capital pool provides a strategic buffer. While early-stage seed and Series A rounds have stabilized, the growth-stage equity market continues to face valuation headwinds. Venture debt serves as a bridge, allowing companies to reach profitability or wait out the macroeconomic cycle before pricing their next equity round. However, the cost of debt remains high, meaning only companies with strong unit economics and clear repayment paths will successfully clear Claret's underwriting hurdles.